Could disease-modifying HIV vaccines cause population-level perversity? (Q34353533)

1 August 2017

Could disease-modifying HIV vaccines cause population-level perversity? (English)

1 reference

ORCID Public Data File 2021

1 August 2017

1 reference

author name string

Robert J Smith

series ordinal

1

1 reference

PubMed ID

15451492

1 August 2017

Sally M Blower

series ordinal

2

1 reference

1 August 2017

1 October 2004

1 reference

Lancet Infectious Diseases

1 August 2017

1 reference

1 August 2017

4

1 reference

1 August 2017

10

1 reference

1 August 2017

636-639

1 reference

Medicine. The need for a global HIV vaccine enterprise

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

HIV Vaccines: A Global Perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

The challenges of an HIV vaccine enterprise

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Public health. A sound rationale needed for phase III HIV-1 vaccine trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Prospects for an AIDS vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

What constitutes efficacy for a human immunodeficiency virus vaccine that ameliorates viremia: issues involving surrogate end points in phase 3 trials

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Estimation of ?needs? and ?probable uptake? for HIV/AIDS preventive vaccines based on possible policies and likely acceptance (a WHO/UNAIDS/IAVI study)

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Prophylactic vaccines, risk behavior change, and the probability of eradicating HIV in San Francisco

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

1 reference

7 January 2021

Modelling HIV vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Imperfect vaccines and herd immunity to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

Live attenuated HIV vaccines: predicting the tradeoff between efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2804%2901148-X

7 January 2021

10.1016/S1473-3099(04)01148-X

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

15451492